Leonard I. Zon, MD

Stem Cell Program and Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Boston, MA

Nancy A. Speck, PhD^1*, Michael Chen^2*, Tomomasa Yokomizo^3*, Brandon Zeigler^4* and Elaine Dzierzak^3*

¹Cell and Developmental Biology, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA
²University of Pennsylvania, Philadelphia, PA
³Erasmus University, Rotterdam, Netherlands
⁴Dartmouth Medical School, Hanover, NH

H. Leighton Grimes, PhD¹, Chinavenmeni S. Velu, PhD², Shane Horman, PhD², Aditya Chaubey, PhD^2*, Tristan Bourdeau, MS^1*, Haiming Xu^3*, Jinfang Zhu, PhD^4*, William Paul, MD^4*, Clemencia Colmenares, PhD^5*, David A. Williams, MD⁶ and Brian Gebelein, PhD^7*

¹Cincinnati Children's Hospital Medical Center, Cincinnati, OH
²Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³Experimental Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁴National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁵Cancer Biology, Cleveland Clinic, Cleveland, OH
⁶Chief, Div. of Hematology/Oncology, Children's Hospital Boston, Leland Fikes, Boston, MA
⁷Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH